Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

NCT04241328 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-04-22

No results posted yet for this study

Summary

The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.

Conditions

Sponsors & Collaborators

  • Medtronic Cardiac Surgery

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-09
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Netherlands
  • Norway
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04241328 on ClinicalTrials.gov